New Partnership to Develop Breath Test for Pneumonia Pathogen
The collaboration aims to create a non-invasive diagnostic for Pseudomonas aeruginosa using miniaturized gas chromatography-mass spectrometry technology.
Read MorePosted by CLP Edit Staff | Dec 16, 2025 | Infectious Diseases |
The collaboration aims to create a non-invasive diagnostic for Pseudomonas aeruginosa using miniaturized gas chromatography-mass spectrometry technology.
Read MorePosted by CLP Edit Staff | Dec 8, 2025 | Lymphoma |
Transaction expands Natera’s solid tumor MRD capabilities and adds ultrasensitive phased variant technology with detection below 0.1 parts per million.
Read MorePosted by CLP Edit Staff | Oct 10, 2025 | Molecular Diagnostic Analyzers |
The machine learning-powered platform analyzes gene expression data from biopsies to provide molecular scores for rejection probability and tissue injury.
Read MorePosted by Chris Wolski | Apr 29, 2025 | Molecular Diagnostics |
Karius, Inc. has launched Karius Focus | BAL, a rapid microbial cell-free DNA test that improves pathogen detection in lung infections.
Read MorePosted by Andy Lundin | Jun 17, 2024 | Transfusion & Transplantation Tests |
Natera launched Prospera Heart with Donor Quantity Score, enhancing its ability to detect rejection in heart transplant patients.
Read More